CIBC Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,030
Closed -$211K 1280
2022
Q2
$211K Sell
10,030
-224
-2% -$4.57K ﹤0.01% 1082
2022
Q1
$241K Hold
10,254
﹤0.01% 1202
2021
Q4
$279K Buy
10,254
+2,867
+39% +$76.8K ﹤0.01% 1129
2021
Q3
$210K Buy
7,387
+166
+2% +$5.06K ﹤0.01% 1332
2021
Q2
$218K Buy
+7,221
New +$213K ﹤0.01% 1230
2021
Q1
Sell
-8,771
Closed -$215K 1355
2020
Q4
$215K Buy
+8,771
New +$165K ﹤0.01% 1102
2017
Q2
Sell
-3,036
Closed -$211K 996
2017
Q1
$211K Hold
3,036
﹤0.01% 898
2016
Q4
$202K Hold
3,036
﹤0.01% 902
2016
Q3
$201K Hold
3,036
﹤0.01% 894
2016
Q2
$220K Buy
+3,036
New +$209K ﹤0.01% 842
2016
Q1
Sell
-2,988
Closed -$214K 957
2015
Q4
$214K Hold
2,988
﹤0.01% 835
2015
Q3
$229K Hold
2,988
﹤0.01% 817
2015
Q2
$221K Sell
2,988
-13
-0.4% -$936 ﹤0.01% 882
2015
Q1
$218K Buy
+3,001
New +$209K ﹤0.01% 885
2014
Q2
Sell
-3,349
Closed -$208K 873
2014
Q1
$208K Buy
+3,349
New +$195K ﹤0.01% 928

Other funds holding MD

CIBC Asset Management's MD Position: Q3 2022 in Review

CIBC Asset Management sold out of Pediatrix Medical (MD) in Q3 2022, closing a stake of 10,030 shares — an estimated $211K sold.

CIBC Asset Management first reported a position in MD in Q1 2014 and held it in 15 quarters. The position peaked at $279K in Q4 2021. 211 funds tracked by Wall St. Rank hold MD as of Q3 2022.

  • CIBC Asset Management reported no remaining Pediatrix Medical position as of Q3 2022 after selling out during the quarter.
  • CIBC Asset Management sold 10,030 Pediatrix Medical shares in Q3 2022, an estimated $211K.
  • CIBC Asset Management first reported a position in Pediatrix Medical in Q1 2014 and held it in 15 quarters.
  • CIBC Asset Management's Pediatrix Medical position peaked at $279K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2022.

Based on CIBC Asset Management's 13F filing for Q3 2022, filed 3 Nov 2022.